Living with multiple sclerosis and rheumatoid Arthritis, Lisa Emrich is an award-winning, passionate patient advocate, health writer, classical musician, and backroad cyclist. Her stories inspire others to live better and stay active. Lisa is author of the blog Brass and Ivory: Life with MS and RA and founder of the Carnival of MS Bloggers. Lisa frequently works with organizations in support of better policies, patient-centered research, and research funding.
Lisa serves on HealthCentral’s Health Advocates Advisory Board, and is a Social Ambassador for the MSHealthCentral Facebook page.
The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.
A number of disease-modifying therapies (DMTs) are effective in decreasing the frequency of relapses and the number of lesions in the brain or spinal cord.
Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.
Multiple sclerosis requires you to learn large amounts of information. During pregnancy, one concern is your MS medication.
Learn the ways that others with MS boost their energy levels, including drinking coffee, exercising, and getting adequate sleep.
If you're so tired, it feels like your soul is tired, you might have severe fatigue, or lassitude. Learn more about this type of fatigue with MS, and what it might mean to your daily life — and what you can do about it.